Elfin Drugs Private Limited, a active private limited company, was established on 25 April 2005 in Mohali, Punjab, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231PB2005PTC028300. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.05 M.
It upholds a compliant status. Employing 19 professional, Its leadership includes Dilpreet Singh (Director), Surinder Jit Kaur (Director). Past directors included Shashi Kumar Sahai, Gurinder Kaur Makkar, Manpreet Kaur. It holds ₹20.42 Cr open charges and ₹18.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at E-206, Industrial Area, Phase-8-B, Mohali, Punjab, 160055.
U24231PB2005PTC028300
028300
25 April 2005
₹7.50 M
₹7.05 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Elfin Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dilpreet Singh | Director | 25 Apr 2005 | Current |
| Surinder Jit Kaur | Director | 19 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Oct 2012 | Past |
| Pramod Abcsdd | Director | 25 Jun 2020 | Past |
| Pramod Abcsdd | Director | 25 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elfin Drugs Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.98% increase. The company also saw a substantial improvement in profitability, with a 20.89% increase in profit. The company's net worth moved up by a moderate rise of 5.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Elfin Drugs had a public holding of 5.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹204,181,338.00
₹185,010,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Apr 2024 | Bank Of India | ₹13.09 Cr | Open |
| 04 Nov 2022 | Hdfc Bank Limited | ₹1.55 M | Open |
| 26 Mar 2021 | Hdfc Bank Limited | ₹0.90 M | Open |
| 01 Feb 2018 | Others | ₹0.70 M | Open |
| 18 Jan 2008 | Oriental Bank Of Commerce | ₹5.54 Cr | Open |
Explore comprehensive loan charge details -
Elfin Drugs has a workforce of 19 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elfin Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elfin Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Elfin Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Bank Of India of Rs. 130.93 M registered on 18 Apr 2024 with Charge ID 100900204 was modified on 08 Aug 2024. was documented.
A charge with Bank Of India amounted to Rs. 130.93 M with Charge ID 100900204 was registered on 18 Apr 2024. was recorded as a recent event.
Progress on Elfin Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
Progress on A charge registered on 04 Sep 2021 via Charge ID 100498253 with Hdfc Bank Limited was fully satisfied on 01 Feb 2024. was documented.
A charge with Hdfc Bank Limited of Rs. 104.61 M registered on 04 Sep 2021 with Charge ID 100498253 was modified on 01 May 2023. was recorded as a recent event.
The CIN of Elfin Drugs Private Limited is U24231PB2005PTC028300.
Elfin Drugs Private Limited is headquartered at E-206, Industrial Area, Phase-8-B, Mohali, Punjab, 160055.
Elfin Drugs Private Limited was incorporated on 25 April 2005.
The current directors of Elfin Drugs Private Limited are
The primary industry of Elfin Drugs Private Limited is Manufacturing.
Elfin Drugs Private Limited is unlisted.
The authorized capital of Elfin Drugs Private Limited is ₹7.50 M, and the paid-up capital is ₹7.05 M.
The compliance status of Elfin Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX